Amlodipine Besylate
Product Images NDC 54868-5761

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 54868-5761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of 5 mg Package Label (5761)

Image Of 5 mg Package Label (5761)
Packaging label for Amlodipine Besylate 5 mg distributed by Physicians Total Care, Inc. The label includes the lot number, expiration date (01/60), barcode, and manufacturer information from Glenmark Pharmaceuticals in Warren, NJ.*
FDA Label Image

Image Of 10 mg Package Label (5762)

Image Of 10 mg Package Label (5762)
Label for Amlodipine Besylate 10mg tablets by Physicians Total Care, Inc. The label indicates a package containing 30 tablets. It includes cautionary information prohibiting dispensing without prescription and standard storage instructions. A barcode and lot number are also visible on the right side.*
FDA Label Image

Image Of 2.5 mg Package Label (5764)

Image Of 2.5 mg Package Label (5764)
Packaging label for Amlodipine Besylate 2.5 mg tablets by Physicians Total Care, Inc. The label indicates a quantity of 30 tablets and includes usage instructions, cautionary information about federal dispensing restrictions, lot number, expiration date, and storage conditions. The label displays a barcode and the labeler name and address.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure of Amlodipine Besylate, showing its molecular arrangement with labeled chemical groups including chlorine, amine, and ester components.*
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
A Kaplan-Meier survival curve comparing event rates over 24 months between Amlodipine and placebo groups. The graph shows lower event rates for Amlodipine compared to placebo, with statistical data including a P-value of 0.003 and a hazard ratio of 0.691 (95% CI: 0.54 to 0.88). The x-axis represents time in months, and the y-axis represents event rate.*
FDA Label Image

Image Of Figure 2 (Figure 2)

Image Of Figure 2 (Figure 2)
A forest plot chart depicting hazard ratios with 95% confidence intervals comparing Amlodipine Besylate versus placebo across various patient subgroups. The subgroups include overall patient population, age groups (<85, >=65), gender (male, female), baseline sitting systolic blood pressure (<= mean, > mean), baseline vessel disease (single, multiple), baseline vessels with stenosis (>=80% stenosis, no stenosis), and PCI-stent strata (no PCI, PCI without stent placement, stent placement). The horizontal axis represents hazard ratios ranging roughly from 0.0 to 2.0, with a vertical line indicating equivalence between treatments.*
FDA Label Image
Image Of Glenmark Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.